Prescription opioid abuse: pharmacists’ perspective and response

References

• Office of National Drug Control PolicyEpidemic: Responding to America’s Prescription Drug Abuse CrisisWashington, DCOffice of National Drug Control Policy, Executive Office of the President of the United States2011
   Google Scholar
• CochranGWooBLo-CiganicWGordonAJDonohueJGelladWDefining non-medical use of prescription opioids within health care claims: a systematic reviewSubst Abus201536219220225671499
   PubMed Web of Science ®Google Scholar
• SmithSMDartRCKatzNPClassification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsPain2013154112287229623792283
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and CrimeWorld Drug Report 2012Vienna, AustriaUnited Nations Office on Drugs and Crime, United Nations2012
   Google Scholar
• International Narcotics Control Board, United NationsNarcotic Drugs: Report 2013 Estimated World Requirements for 2014 – Statistics for 2012Vienna, Austria: United NationsInternational Narcotics Control_Board2013
   Google Scholar
• ManchikantiLNational drug control policy and prescription drug abuse: facts and fallaciesPain Physician200710339942417525776
   PubMedGoogle Scholar
• ManchikantiLFellowsBAilinaniHPampatiVTherapeutic use, abuse, and nonmedical use of opioids: a ten-year perspectivePain Physician2010125401435
   Google Scholar
• HanksSThe law of unintended consequences: when pain management leads to medication errorsPT2008337420425
   Google Scholar
• Van ZeeAThe promotion and marketing of OxyContin: commercial triumph, public health tragedyAm J Public Health200999222122718799767
   PubMed Web of Science ®Google Scholar
• ComerSDSullivanMAWhittingtonRAVosburgSKKowalczykWJAbuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusersNeuropsychopharmacology20083351179119117581533
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGuidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid DependenceGeneva, SwitzerlandWorld Health Organization2009
   Google Scholar
• Substance Abuse and Mental Health Services AdministrationResults from the 2012 National Survey on Drug Use and Health: Summary of National FindingsRockville, MDSubstance Abuse and Mental Health Services Administration2013
   Google Scholar
• MeyerRPatelAMRattanaSKQuockTPModySHPrescription opioid abuse: a literature review of the clinical and economic burden in the United StatesPopul Health Manag201417637238725075734
   PubMed Web of Science ®Google Scholar
• CepedaMSFifeDChowWMastrogiovanniGHendersonSCAssessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the USDrug Saf201235432533422339505
   PubMed Web of Science ®Google Scholar
• HallAJLoganJEToblinRLPatterns of abuse among unintentional pharmaceutical overdose fatalitiesJAMA2008300222613262019066381
   PubMed Web of Science ®Google Scholar
• MuhuriPGfroererJDaviesCAssociations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United StatesRockville, MDCenter for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration2013
   Google Scholar
• ComptonWMJonesCMBaldwinGTRelationship between nonmedical prescription-opioid use and heroin useN Engl J Med2016374215416326760086
   PubMed Web of Science ®Google Scholar
• CiceroTJEllisMSSurrattHLKurtzSPThe changing face of heroin use in the United States: a retrospective analysis of the past 50 yearsJAMA Psychiatry201471782182624871348
   PubMed Web of Science ®Google Scholar
• WhiteAGBirnbaumHGSchillerMTangJKatzNPAnalytic models to identify patients at risk for prescription opioid abuseAm J Manag Care2009151289790620001171
   PubMed Web of Science ®Google Scholar
• SullivanMDEdlundMJFanM-YDevriesABrennan BradenJMartinBCRisks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP StudyPain2010150233233920554392
   PubMed Web of Science ®Google Scholar
• BeckerWCSullivanLETetraultJMDesaiRAFiellinDANon-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlatesDrug Alcohol Depend2008941–3384718063321
   PubMed Web of Science ®Google Scholar
• AmariERehmJGoldnerEFischerBNonmedical prescription opioid use and mental health and pain comorbidities: a narrative reviewCan J Psychiatry201156849550221878161
   PubMed Web of Science ®Google Scholar
• HuangBDawsonDAStinsonFSPrevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related ConditionsJ Clin Psychiatry20066771062107316889449
   PubMed Web of Science ®Google Scholar
• MartinsSSKeyesKMStorrCLZhuHChilcoatHDPathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related ConditionsDrug Alcohol Depend20091031–2162419414225
   PubMed Web of Science ®Google Scholar
• NovakSPHerman-StahlMFlanneryBZimmermanMPhysical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United StatesDrug Alcohol Depend20091001–2637019010611
   PubMed Web of Science ®Google Scholar
• RiceJBWhiteAGBirnbaumHGSchillerMBrownDARolandCLA model to identify patients at risk for prescription opioid abuse, dependence, and misusePain Med20121391162117322845054
   PubMed Web of Science ®Google Scholar
• UnickGJRosenblumDMarsSCiccaroneDIntertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009PLoS One201382e54496e5449623405084
   PubMed Web of Science ®Google Scholar
• BrakerLSReeseAECardROVan HoweRSScreening for potential prescription opioid misuse in a Michigan Medicaid populationFam Med2009411072919882397
   PubMed Web of Science ®Google Scholar
• HudsonTJEdlundMJSteffickDETripathiSPSullivanMDEpidemiology of regular prescribed opioid use: results from a national, population-based surveyJ Pain Symptom Manage200836328028818619768
   PubMed Web of Science ®Google Scholar
• EdlundMJMartinBCFanM-YBradenJBDevriesASullivanMDAn analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP studyJ Pain Symptom Manage201040227928920579834
   PubMed Web of Science ®Google Scholar
• BenyaminRTrescotADattaSOpioid complications and side effectsPain Physician2008112 supplS105S12018443635
   PubMed Web of Science ®Google Scholar
• UpadhyayJMalekiNPotterJAlterations in brain structure and functional connectivity in prescription opioid-dependent patientsBrain2010133pt 72098211420558415
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionVital Signs: Overdoses of Prescription Opioid Pain Relievers – United States, 1999–2008Atlanta, GACenters for Disease Control and Prevention2011
   Google Scholar
• Centers for Disease Control and Preventionwebpage on the InternetPrescription Drug Overdose Data: Deaths from Prescription Opioid Overdose2015 Available from: http://www.cdc.gov/drugoverdose/data/overdose.htmlAccessed July 16, 2015
   Google Scholar
• JonesCMMackKAPaulozziLJPharmaceutical overdose deaths, United States, 2010JAMA2013309765765923423407
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration2014 National Drug Threat Assessment SummaryFt. Bliss, TXDrug Enforcement Administration Strategic Intelligence Section2014
   Google Scholar
• KingSAPreventing prescription opioid abuse: new formulations – but who will benefit?Psychiatr Times200926216
   Google Scholar
• SevertsonSGBartelsonBBDavisJMReduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010J Pain201314101122113023816949
   PubMed Web of Science ®Google Scholar
• RosenblattRAAndrillaCHCatlinMLarsonEHGeographic and specialty distribution of US physicians trained to treat opioid use disorderAnn Fam Med2015131232625583888
   PubMed Web of Science ®Google Scholar
• ClarkTEadieJKnuePKreinerPStricklerGPrescription Drug Monitoring Programs: An Assessment of the Evidence for Best PracticesWaltham, MAHeller School for Social Policy and Management, Brandeis University2012
   Google Scholar
• Prescription Drug Monitoring Program Center of ExcellenceBriefing on PDMP EffectivenessWaltham, MAPrescription Drug Monitoring Program Center of Excellence at Brandeis2013
   Google Scholar
• PaulozziLJKilbourneEMDesaiHAPrescription drug monitoring programs and death rates from drug overdosePain Med201112574775421332934
   PubMed Web of Science ®Google Scholar
• ShepherdJCombating the prescription painkiller epidemic: a national prescription drug reporting programAm J Law Med20144018511224844043
   PubMed Web of Science ®Google Scholar
• PerroneJNelsonLSMedication reconciliation for controlled substances – an “ideal” prescription-drug monitoring programN Engl J Med2012366252341234322646509
   PubMed Web of Science ®Google Scholar
• CochranGGordonAJFieldCDeveloping a framework of care for opioid medication misuse in community pharmacyRes Social Adm Pharm201612229330126048710
   PubMed Web of Science ®Google Scholar
• CrozierMKMcMillanSHudsonSJonesSThe eastern North Carolina opioid prescribers project: a model continuing medical education workshopJ Opioid Manag20106535936421046933
   PubMedGoogle Scholar
• IslamMMMcRaeISAn inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensionsBMC Pharmacol Toxicol2014154625127880
   PubMed Web of Science ®Google Scholar
• PringleJLBoyerAConklinMHMcCulloughJWAldridgeAThe Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costsHealth Aff201433814441452
   Web of Science ®Google Scholar
• KhanNSNormanIJDhitalRMcCronePMilliganPWhittleseaCMAlcohol brief intervention in community pharmacies: a feasibility study of outcomes and customer experiencesInt J Clin Pharm20133561178118724013957
   PubMed Web of Science ®Google Scholar
• BacciJLMcGrathSHPringleJLMaguireMAMcGivneyMSImplementation of targeted medication adherence interventions within a community chain pharmacy practice: the Pennsylvania ProjectJ Am Pharm Assoc2014546584593
   Google Scholar
• CerulliJZeollaMMImpact and feasibility of a community pharmacy bone mineral density screening and education programJ Am Pharm Assoc2004442161167
   Google Scholar
• LystlundSStevensEPlanasLGMarcyTRPatient participation in a clinic-based community pharmacy medication take-back programJ Am Pharm Assoc2014543280284
   Google Scholar
• StewartHMalinowskiAOchsLJaramilloJMcCallK3rdSullivanMInside Maine’s Medicine Cabinet: Findings from the Drug Enforcement Administration’s Medication Take-Back EventsAm J Public Health20151051e65e71
   PubMed Web of Science ®Google Scholar
• ThachAVBrownCMPopeNConsumer perceptions about a community pharmacy-based medication take back programJ Environ Manage2013127232723669605
   PubMed Web of Science ®Google Scholar
• WelhamGCMountJKGilsonAMType and frequency of opioid pain medications returned for disposalDrugs Real World Outcomes20152212913526317067
   PubMedGoogle Scholar
• BeletskyLRichJDWalleyAYPrevention of fatal opioid overdoseJAMA2012308181863186423150005
   PubMed Web of Science ®Google Scholar
• CheatleMDPrescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safetyPain Med201516suppl 1S3S826360931
   PubMed Web of Science ®Google Scholar
• KolodnyACourtwrightDTHwangCSThe prescription opioid and heroin crisis: a public health approach to an epidemic of addictionAnnu Rev Public Health20153655957425581144
   PubMed Web of Science ®Google Scholar
• GreenTCDauriaEFBratbergJDavisCSWalleyAYOrienting patients to greater opioid safety: models of community pharmacy-based naloxoneHarm Reduct J2015122526245865
   PubMed Web of Science ®Google Scholar
• American Association of Public Health [webpage on the Internet]APHA Policy Statement LB-12-02 – Preventing Overdose Through Education and Naloxone DistributionWashington, DC2016 Available from: https://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/16/13/08/reducing-opioid-overdose-through-education-and-naloxone-distribution#Accessed April 11, 2016
   Google Scholar
• SporerKAAcute heroin overdoseAnn Intern Med1999130758459010189329
   PubMed Web of Science ®Google Scholar
• CoffinPOFullerCVadnaiLBlaneySGaleaSVlahovDPreliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York CityJ Urban Health200380228829012791804
   PubMed Web of Science ®Google Scholar
• WheelerEJonesTSGilbertMKDavidsonPJOpioid overdose prevention programs providing naloxone to laypersons – United States, 2014MMWR Morb Mortal Wkly Rep2015642363163526086633
   PubMed Web of Science ®Google Scholar
• WalleyAYXuanZHackmanHHOpioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysisBMJ2013346f17423372174
   PubMed Web of Science ®Google Scholar
• CoffinPOSullivanSDCost-effectiveness of distributing naloxone to heroin users for lay overdose reversalAnn Intern Med201315811923277895
   PubMed Web of Science ®Google Scholar
• BratbergJJacksonAPart II: law: educating and empowering patients and caregivers: the pharmacist’s role in reducing the risk of opioid overdoseDrug Topics20165165
   Google Scholar
• OkieSA flood of opioids, a rising tide of deathsN Engl J Med2010363211981198521083382
   PubMed Web of Science ®Google Scholar
• RobinsonMwebpage on the InternetCombating Opioid Drug Abuse with Naloxone2015 Available from: https://www.pharmacist.com/combating-opioid-drug-abuse-naloxoneAccessed Feburary, 2016
   Google Scholar
• American Pharmacists AssociationActions of the 2015 APhA House of DelegatesSan Diego, CAAmerican Pharmacists Association2015
   Google Scholar
• American Pharmacists AssociationAmerican Pharmacists Association Policy ManualWashington, DCAmerican Pharmacists Association2015
   Google Scholar
• Office of the Press SecretaryWhite House Obama Administration Announces Public and Private Sector Efforts to Address Prescription Drug Abuse and Heroin Use [Press Release]Washington DCOffice of the Press Secretary2012
   Google Scholar
• American Society of Health-System PharmacistsAmerican Society of Health-System Pharmacists Statement on the Pharmacist’s Role in Substance Abuse Prevention, Education, and AssistanceWashington, DCAmerican Society of Health-System Pharmacists2015
   Google Scholar
• LaffertyLHunterTSMarshWAKnowledge, attitudes and practices of pharmacists concerning prescription drug abuseJ Psychoactive Drugs200638322923217165365
   PubMed Web of Science ®Google Scholar
• CochranGFieldCLawsonKPharmacists who screen and discuss opioid misuse with patients: future directions for research and practiceJ Pharm Pract201528440441224532819
   PubMedGoogle Scholar
• WenthurCJCrossBSVernonVPOpinions and experiences of Indiana pharmacists and student pharmacists: the need for addiction and substance abuse education in the United StatesRes Social Adm Pharm2013919010022695219
   PubMed Web of Science ®Google Scholar
• HagemeierNEAlamianAMurawskiMMPackRPFactors associated with provision of addiction treatment information by community pharmacistsJ Subst Abuse Treat201552677225491734
   PubMed Web of Science ®Google Scholar
• American Association of Colleges of PharmacyCurricular Guidelines for Pharmacy: Substance Abuse and Addictive DiseaseAlexandria, VAAmerican Association of Colleges of Pharmacy2010
   Google Scholar
• American Pharmacists Association [webpage on the Internet]Institute on Alcoholism and Drug Dependencies American Pharmacists Association 20162016 Available from: http://www.pharmacist.com/apha-institute-alcoholism-and-drug-dependencies-program-objectivesAccessed February 22, 2016
   Google Scholar
• American Pharmacists AssociationGeneration Rx [webpage on the Internet]American Pharmacists Association Academy of Student Pharmacists2016 Available from: http://www.pharmacist.com/apha-asp-generation-rxAccessed February 22, 2016
   Google Scholar
• GenerationRx [homepage on the Internet]Generation Rx Safe Medication Practices for Life2016 Available from: http://www.generationrx.org/Accessed February 21, 2016
   Google Scholar
• Centers for Disease Control and PreventionSelect Features of State Pharmacist Collaborative Practice LawsAtlanta, GAUS Department of Health and Human Services, Centers for Disease Control and Prevention2013
   Google Scholar
• FoucheCButlerRShawJAtypical alliances: the potential for social work and pharmacy collaborations in primary health care deliverySoc Work Health Care201352978980724117029
   PubMed Web of Science ®Google Scholar
• FallisJA view from a roomCan Pharm J20121456254255
   Google Scholar
• MobachMPThe counter and consultation room work explored in the NetherlandsPharm World Sci200830436036618193337
   PubMedGoogle Scholar
• American Society of Health System PharmacistsAmerican Society of Health System Pharmacists Guidelines on Pharmacist-Conducted Patient Education and CounselingBethesda, MDAmerican Society of Health System Pharmacists1997
   Google Scholar
• CochranGRubinsteinJBacciJLYliojaTTarterRScreening community pharmacy patients for risk of prescription opioid misuseJ Addict Med20159541141626291546
   PubMed Web of Science ®Google Scholar
• American Pharmacist Associating, National Association of Chain Drug Stores FoundationMedication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0)J Am Pharm Assoc (2003)20084834135318595820
   PubMedGoogle Scholar
• BlumlBMDefinition of medication therapy management: development of professionwide consensusJ Am Pharm Assoc2005455566572
   Google Scholar
• PerlrothDMarrufoGMontesinosAMedication Therapy Management in Chronically Ill Populations: Final ReportBurlingame, CAAcumen, LLC2013
   Google Scholar
• CookPFEmiliozziSWatersCEl HajjDEffects of telephone counseling on antipsychotic adherence and emergency department utilizationAm J Manag Care2008141284184619067501
   PubMed Web of Science ®Google Scholar
• HillSKavookjianJMotivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: a systematic review of the literatureAIDS Care201224558359222292452
   PubMed Web of Science ®Google Scholar
• TaitelMJiangJRudkinKEwingSDuncanIThe impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapyPatient Prefer Adherence2012632332922563240
   PubMed Web of Science ®Google Scholar
• KaplanJEKeeleyRDEngelMEmsermannCBrodyDAspects of patient and clinician language predict adherence to antidepressant medicationJ Am Board Fam Med201326440942023833156
   PubMed Web of Science ®Google Scholar
• BarkhofEMeijerCJde SonnevilleLMLinszenDHde HaanLThe effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophreniaSchizophr Bull20133961242125124072808
   PubMed Web of Science ®Google Scholar
• AlfordDPOpioid prescribing for chronic pain – achieving the right balance through educationN Engl J Med2016374430130326816007
   PubMed Web of Science ®Google Scholar